The malignant wound assessment tool: a validation study using a Delphi approach

Abstract

Malignant wounds, caused by the direct invasion of cancer into the skin, occur in cancer patients with primary skin tumours and as cutaneous metastasis in approximately 10% of patients with metastatic internal malignancies. Malignant wounds have a profound impact on patients, family members and health care providers. The assessment of the patient with malignant wounds can be complex and there is no widely accepted, consistent approach. Valid, descriptive survey research methods were used to develop the Malignant Wound Assessment Tool (MWAT). The authors developed two versions of the MWAT: a brief clinical version (MWAT-C) and a more detailed research version (MWAT-R). Domains include clinical wound features, physical effects and emotional and social impacts of the wound. The two tools underwent content and construct validity testing using a Delphi process. An international panel of professionals with clinical or research expertise related to malignant wounds was formed. Panelists participated in two rounds of review for each tool. Development and face validity testing of the MWAT-C and MWAT-R tools through the Delphi process have resulted in tools ready for clinical application and will support clinical and research activities to improve care for patients with this devastating condition.

Keywords

assessment tool cancer Delphi technique malignant wound palliative care validation

References

1 Lookingbill DP Spangler N Helm KF . Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228–236.

2 Maida V Corb M Dolzyhkov M Ennis M Irani S Trozzolo L . Wounds in advance illness: a prevalence and incidence study base on a prospective case series. Int Wound J 2008; 5: 305–314.

3 Seaman S . Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 2006; 22: 185–193.

4 Haisfield-Wolfe ME Baxendale-Cox LM . Staging of malignant cutaneous wounds: a pilot study. Oncol Nurs Forum 1999; 26: 1055–1064.

5 Naylor WA . A guide to wound management in palliative care. Int J Palliat Nurs 2005; 11: 572–579.

6 Schulz VN . Malignant wounds and pressure ulcers. In: N MacDonald D Oneschuk N Hagen D Doyle , (eds), Palliative medicine: a case-based manual, 2nd ed. New York: Oxford University Press; 2005. p. 333–348.

8 Lazelle-Ali C . Psychological and physical care of malodorous fungating wounds. Br J Nurs 2007; 16: S16–S24.

9 Bolton L Van RL . Wound dressings: meeting clinical and biological needs. Dermatol Nurs 1991; 3: 146–161.

10.

11.

11 Lavery LA Armstrong DG Harkless LB . Classification of diabetic foot wounds. Ostomy Wound Manage 1997; 43: 44–43.

12.

12 Beebe HG Bergan JJ Bergqvist D . Classification and grading of chronic venous disease in the lower limbs. A consensus statement of the North American Society of Phlebology. Dermatol Surg 1995; 21: 642–646.

13.

13 van Rijswijk L . Wound assessment and documentation. In: DL Krasner GY Rodeheaver GR Sibbald , (eds), Chronic wound care: a clinical sourcebook for healthcare professionals, 3rd ed. Wayne (PA): HMP Communications; 2001. p. 101–115.

14.

14 Weir D . Pressure ulcers: assessment, classification, and management. In: DL Krasner GY Rodeheaver GR Sibbald , (eds), Chronic wound care: a clinical sourcebook for healthcare professionals, 3rd ed. Wayne (PA): HMP Communications; 2001. p. 619–927.

15.

15 Grocott P Brown N Cowley S . Quality of life: assessing the impact and benefits of care to patients with fungating wounds. Wounds 2005; 17: 8–15.

16.

17.

17 Foltz AT . Nursing care of ulcerating metastatic lesions. Oncol Nurs Forum 1980; 7: 8–13.

18.

18 Schulz VMN; . The development of a malignant wound assessment tool. Unpublished thesis, Edmonton, Alberta, Canada: University of Alberta; 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/MQ60406.pdf [accessed 2.07.08].

19.

19 Schulz V Triska OH Tonkin K . Malignant wounds: caregiver-determined clinical problems. J Pain Symptom Manage 2002; 24: 572–577.

20.

20 Dalkey NC . The Delphi method: an experimental study of group opinion. Santa Monica (CA): Rand Corp.; 1969.

21.

21 Boberg AL Morris-Khoo SA . The Delphi method: a review of methodology and an application in the evaluation of a higher education program. Can J Program Eval 1992; 7: 27–39.

22.

22 McKenna HP . The Delphi technique: a worthwhile research approach for nursing? J Adv Nurs 1994; 19: 1221–1225.

23.

23 Chochinov HM Hack T McClement S Kristjanson L Harlos M . Dignity in the terminally ill: a developing empirical model. Soc Sci Med 2002; 54: 433–443.

24.

24 Hagen NA Stiles C Nekolaichuk C Biondo P Carlson LE Fisher K . The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a Delphi process and patient think-aloud interviews. J Pain Symptom Manage 2008; 35: 136–152.

25.

25 Biondo PD Nekolaichuk CL Stiles C Fainsinger R Hagen NA . Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer 2007; 16: 935–942.

26.

26 Nekolaichuk CL Fainsinger RL Lawlor PG . A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med 2005; 19: 466–476.